奥曲肽（SMS 201-995）治疗转移性胰高血糖素瘤：1例报告并文献复习
Octreotide (SMS 201-995) in the treatment of metastatic glucagonoma: report of one case and review of the literature.
作者信息
Rosenbaum A, Flourie B, Chagnon S, Blery M, Modigliani R
机构信息
Service de Gastroentérologie, Hôpital Saint-Lazare, Paris, France.
出版信息
Digestion. 1989;42(2):116-20. doi: 10.1159/000199835.
PMID:2548911
Abstract
We report 1 patient with a necrolytic migratory erythema, a high plasma glucagon concentration and a metastatic pancreatic endocrine tumor who has now been treated effectively for 33 months with the somatostatin analogue octreotide (SMS 201-995) (400 micrograms/day). The results of SMS 201-995 in the treatment of glucagonoma syndrome are reviewed.
摘要
我们报告1例患有坏死性游走性红斑、高血浆胰高血糖素浓度及转移性胰腺内分泌肿瘤的患者，该患者目前已使用生长抑素类似物奥曲肽（SMS 201-995）（400微克/天）有效治疗33个月。本文回顾了SMS 201-995治疗胰高血糖素瘤综合征的结果。
Zotero 插件